Match each obstetric clinical scenario to the most appropriate targeted pharmacologic intervention, taking into account the specific indications and contraindications for each patient.
- Postpartum hemorrhage due to uterine atony in a normotensive patient with a history of severe persistent asthma; initial oxytocin therapy has failed.Methylergonovine
- Postpartum hemorrhage due to uterine atony in a patient with preeclampsia and a current blood pressure of mmHg; initial oxytocin therapy has failed.Carboprost tromethamine
- New-onset generalized tonic-clonic seizures in a patient at weeks gestation with severe headache, proteinuria, and a blood pressure of mmHg.Magnesium sulfate
- Preterm labor at weeks gestation in a patient with a documented history of myasthenia gravis requiring tocolytic therapy.Nifedipine
Cevap
The scenarios match to their respective interventions based on critical contraindications: the asthmatic patient receives methylergonovine, the hypertensive patient receives carboprost tromethamine, the eclamptic patient receives magnesium sulfate, and the myasthenia gravis patient receives nifedipine.
Correct matching relies on pairing the clinical presentation with the drug that avoids the patient's absolute contraindications while effectively treating the underlying obstetric emergency.
Adım Adım Çözüm
Anahtar Kavram
Pharmacological management of acute obstetric complications requires precise selection of uterotonics, anticonvulsants, and tocolytics by identifying strict maternal contraindications (e.g., asthma, hypertension, myasthenia gravis).